COVID-19 testing: FDA approves saliva collection test from Rutgers

The FDA has granted emergency use authorization (EUA) to Rutgers' RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency. The new saliva collection method, which RUCDR developed in partnership with Spectrum Solutions and Accurate ["]

The post COVID-19 testing: FDA approves saliva collection test from Rutgers appeared first on Outbreak News Today.